GGrantIndex
← Leaderboards

Cristina R Antonescu

Sloan-Kettering Inst Can Research

$10,810,455
Attributed
$10,810,455
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,810,455 · 6

By mechanism

P50$9,803,839 · 5
P01$1,006,616 · 1

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Others in their field

Top investigators on “Sarcoma

Research focus

SarcomaDesignPathologicTumorMouse ModelResponseResourcesEvaluationMolecularGenesCell LineSamplingPilot ProjectsPharmaceutical PreparationsMutationGenerationsProgramsDatabasesHuman TissueProtocols DocumentationFreezingPhosphotransferasesNormal Tissue MorphologyNecrosis

Grant awards (29)

Core A: Biospecimen Repository and Pathology$217,928
P50 · FY2025 · CA · contact PI
Core A: Biospecimen Repository and Pathology$209,143
P50 · FY2024 · CA · contact PI
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)$246,736
P50 · FY2023 · CA · contact PI
CF 1: Biospecimen Repository Core$103,502
P50 · FY2023 · CA · contact PI
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)$361,735
P50 · FY2022 · CA · contact PI
CF 1: Biospecimen Repository Core$169,405
P50 · FY2022 · CA · contact PI
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)$361,734
P50 · FY2021 · CA · contact PI
CF 1: Biospecimen Repository Core$169,404
P50 · FY2021 · CA · contact PI
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)$366,111
P50 · FY2020 · CA · contact PI
CF 1: Biospecimen Repository Core$173,779
P50 · FY2020 · CA · contact PI
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)$351,298
P50 · FY2019 · CA · contact PI
CF 1: Biospecimen Repository Core$172,433
P50 · FY2019 · CA · contact PI
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)$377,740
P50 · FY2018 · CA · contact PI
CF 1: Biospecimen Repository Core$185,410
P50 · FY2018 · CA · contact PI
P1 - Molecular Mechanisms of KIT Signaling and Imatinib Resistance in GIST$1,157,566
P50 · FY2014 · CA · contact PI
C1 - Biospecimen Repository Core$73,580
P50 · FY2014 · CA · contact PI
P1 - Molecular Mechanisms of KIT Signaling and Imatinib Resistance in GIST$1,151,938
P50 · FY2013 · CA · contact PI
C1 - Biospecimen Repository Core$72,928
P50 · FY2013 · CA · contact PI
P1 - Molecular Mechanisms of KIT Signaling and Imatinib Resistance in GIST$1,232,964
P50 · FY2012 · CA · contact PI
C1 - Biospecimen Repository Core$77,781
P50 · FY2012 · CA · contact PI
P1 - Molecular Mechanisms of KIT Signaling and Imatinib Resistance in GIST$1,172,227
P50 · FY2011 · CA · contact PI
C1 - Biospecimen Repository Core$73,683
P50 · FY2011 · CA · contact PI
P1 - Molecular Mechanisms of KIT Signaling and Imatinib Resistance in GIST$1,248,914
P50 · FY2010 · CA · contact PI
Pathology$234,446
P01 · FY2010 · CA · contact PI
C1 - Biospecimen Repository Core$75,900
P50 · FY2010 · CA · contact PI
Pathology$229,751
P01 · FY2009 · CA · contact PI
Pathology$222,961
P01 · FY2008 · CA · contact PI
Pathology$220,651
P01 · FY2007 · CA · contact PI
Pathology$98,807
P01 · FY2006 · CA · contact PI